Back to search
NPDR - Non Proliferative Diabetic Retinopathy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which NPDR - Non Proliferative Diabetic Retinopathy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which NPDR - Non Proliferative Diabetic Retinopathy trials you may qualify forThe purpose of this trial is to study the safety and effectiveness of OTX-TKI (axitinib intravitreal hydrogel) for the treatment of Non-Proliferative Diabetic R…
Pilot, single-site, prospective study of QLS-111 0.015 % in subjects with NPDR, OAG or NTG
The goal of this clinical trial is to learn about the safety of the investigational medicinal product ANXV. It will also learn about how ANXV works to treat non…
This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of fol…
The goal of this clinical trial is to learn if drug TNTL works to treat non-proliferative diabetic retinopathy in adults. It will also learn about the safety of…
Patients with diabetic macular edema (DME) sometimes must undergo vitrectomy surgery (PPV) for diabetic and non-diabetic related issues. Patients may have impro…
This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high severity can join the study.…
The purpose of this Phase 2 study is comprised of two groups to evaluate the safety, tolerability, and efficacy of faricimab in patients with Non-Proliferative…
Phase 2 study to assess the efficacy of topically administered eyedrops of INV-102 during a 12-week dosing period in subjects with non-center involved DME (NCID…